Thomas J. H. Chen

发表

Trends in Major Incidents of Semiconductor-Related Industry in Taiwan

Yih-Shing Duh, Chen-Shan Kao, William W.-L. Lee, 2008 .

Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment?

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2012, Molecular Neurobiology.

The Addictive Brain: All Roads Lead to Dopamine

Thomas J. H. Chen, K. Blum, D. Barh, 2012, Journal of psychoactive drugs.

Attention-deficit-hyperactivity disorder and reward deficiency syndrome

Thomas J Prihoda, Kenneth Blum, Thomas J. H. Chen, 2008, Neuropsychiatric disease and treatment.

The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors

Thomas J. H. Chen, D. Comings, K. Blum, 2000, Journal of psychoactive drugs.

Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE® device therapy: a case series

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Cases journal.

Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2009, Postgraduate medicine.

A 21ST CENTURY PERSPECTIVE ON DEPRESSION, REWARD GENES, AND DNA POLYMORPHIC TARGETED NUTRIGENOMIC RESOLUTION

Thomas J. H. Chen, K. Blum, D. Baron, 2017 .

Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.

Thomas J. H. Chen, K. Blum, M. Febo, 2018, Frontiers in bioscience.

Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map

William B. Downs, Thomas J. H. Chen, K. Blum, 2011, Journal of psychoactive drugs.

Repetitive H-Wave® device stimulation and program induces significant increases in the range of motion of post operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study

Thomas J. H. Chen, K. Blum, E. Braverman, 2009, BMC musculoskeletal disorders.

The H-Wave® Device Induces NO-dependent Augmented Microcirculation and Angiogenesis, Providing Both Analgesia and Tissue Healing in Sports Injuries

Thomas J. H. Chen, K. Blum, E. Braverman, 2008, The Physician and sportsmedicine.

Clinical evidence for effectiveness of phencal in maintaining weight loss in an open-label, controlled, 2-year study

Thomas J. H. Chen, E. Braverman, R. Wood, 1997 .

Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant

C. A. Gordon, Thomas J. H. Chen, B. Meshkin, 2006, Advances in therapy.

Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders.

Thomas J. H. Chen, D. Comings, K. Blum, 2005, Medical hypotheses.

Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study

William B. Downs, Margaret A. Madigan, Thomas J. H. Chen, 2012, Journal of psychoactive drugs.

H-Wave® effects on blood flow and angiogenesis in longitudinal studies in rats.

Thomas L. Smith, Thomas J. H. Chen, K. Blum, 2011, Journal of surgical orthopaedic advances.

Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions.

Thomas J. H. Chen, K. Blum, M. Oscar-Berman, 2009, Medical hypotheses.

Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands

L. D. White, Thomas J. H. Chen, K. Blum, 2008 .

Author ' s response to reviews Title : Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia : a clinical study

Thomas J. H. Chen, K. Blum, E. Braverman, 2008 .

Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report.

Thomas J. H. Chen, K. Blum, D. Barh, 2012, Food & function.

Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence Behaviors

Margaret A. Madigan, Thomas J. H. Chen, D. Comings, 2011, International journal of environmental research and public health.

Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths

Thomas J. H. Chen, D. Comings, B. Meshkin, 2005, Theoretical Biology and Medical Modelling.

Chromium Picolinate (CrP) a putative anti-obesity nutrient induces changes in body composition as a function of the Taq1 dopamine D2 receptor polymorphisms in a randomized double-blind placebo controlled study

L. D. White, Thomas J. H. Chen, D. Comings, 2007 .

Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.

Thomas J. H. Chen, K. Blum, E. Braverman, 2004, Medical hypotheses.

Putative targeting of Dopamine D2 receptor function in Reward Deficiency Syndrome (RDS) by Synaptamine Complex™ Variant (KB220): Clinical trial showing anti-anxiety effects

Thomas J. H. Chen, K. Blum, E. Braverman, 2009 .

Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome

Thomas J. H. Chen, B. Meshkin, K. Blum, 2007, Advances in therapy.

Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2 Agonist Therapy: Part 2

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Postgraduate medicine.

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary

Thomas J. H. Chen, D. Comings, K. Blum, 2008, Theoretical Biology and Medical Modelling.

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

Thomas J. H. Chen, K. Blum, M. Oscar-Berman, 2011, Molecular Neurobiology.

Nutrigenomic targeting of carbohydrate craving behavior: can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map?

Thomas J. H. Chen, K. Blum, M. Oscar-Berman, 2009, Medical hypotheses.

LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome

Thomas J. H. Chen, K. Blum, T. Palomo, 2008, Advances in therapy.

Mesolimbic Reward Circuitry and Reward Deficiency Syndrome (RDS): A Commentary on Long Term Dopaminergic Therapy

Thomas J. H. Chen, K. Blum, Amanda L. C. Chen, 2008 .

Attention-defi cit-hyperactivity disorder and reward defi ciency syndrome

Thomas J. H. Chen, D. Comings, K. Blum, 2008 .

Attention-de fi cit-hyperactivity disorder and reward de fi ciency syndrome

Thomas J. H. Chen, D. Comings, K. Blum, 2008 .

Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).

C. A. Gordon, Thomas J. H. Chen, B. Meshkin, 2007, Medical hypotheses.

Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.

Thomas J. H. Chen, B. Meshkin, K. Blum, 2007, Medical hypotheses.

Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers: Evidenced Based on Statistical Reevaluation of Current Literature

William B. Downs, Thomas J. H. Chen, K. Blum, 2008, Journal of psychoactive drugs.

Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Current neuropharmacology.

Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender

Thomas J. H. Chen, K. Blum, E. Braverman, 2009, BMC Research Notes.

Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: Evidence supported by structural equation modeling (SEM) parameter estimates

Thomas J. H. Chen, B. Meshkin, K. Blum, 2007, AGE.

The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis

Thomas J. H. Chen, K. Blum, E. Braverman, 2008, Advances in therapy.

The H-Wave® small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study

Thomas J. H. Chen, B. Meshkin, K. Blum, 2006, Advances in therapy.

H-wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study

Thomas L. Smith, Thomas J. H. Chen, B. Meshkin, 2006, Advances in therapy.

Thomas J. H. Chen, K. Blum, E. Braverman, 2009, BMC Endocrine Disorders.

A short term pilot open label study to evaluate efficacy and safety of LG 839 , a customized DNA directed nutraceutical in obesity : Exploring Nutrigenomics Research

William B. Downs, Thomas J. H. Chen, K. Blum, 2009 .

A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics

William B. Downs, Thomas J. H. Chen, K. Blum, 2008 .

Health economics of nutrigenomics in weight management

Thomas J. H. Chen, B. Meshkin, K. Blum, 2008 .

Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).

Margaret A. Madigan, Kenneth Blum, Thomas J. H. Chen, 2010, Medical hypotheses.

Enhancement of Attention Processing by Kantroll™ in Healthy Humans: A Pilot Study

Thomas J. H. Chen, F. C. Schweitzer, K. Blum, 1997, Clinical EEG.

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting

C. A. Gordon, Thomas J. H. Chen, B. Meshkin, 2006, Advances in therapy.

Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia

Kenneth Blum, Uma Damle, Thomas J. H. Chen, 2010, Neuropsychiatric disease and treatment.

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Journal of medical case reports.

Nutrigenomics and pharmacogenomics: a scientific wonderland

Thomas J. H. Chen, B. Meshkin, K. Blum, 2006 .

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.

Thomas J. H. Chen, D. Comings, K. Blum, 1995, Pharmacogenetics.

Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.

Margaret A. Madigan, Thomas J. H. Chen, D. Comings, 2011, International journal of environmental research and public health.

Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender

Thomas J. H. Chen, K. Blum, E. Braverman, 2009 .

Thomas J. H. Chen, K. Blum, E. Braverman, 2009, BMC Endocrine Disorders.

Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Medical hypotheses.

Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2009, Postgraduate medicine.

Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence Behaviors

Margaret A. Madigan, Thomas J. H. Chen, D. Comings, 2011, International journal of environmental research and public health.

Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.

Thomas J. H. Chen, K. Blum, M. Taub, 1996, Pharmacogenetics.

Preliminary association of both the Dopamine D2 Receptor (DRD2) (Taq1 A1 Allele) and the Dopamine Transporter (DAT1) (480 bp Allele) genes with pathological aggressive behavior, a clinical subtype of Reward Deficiency Syndrome (RDS) in adolescents

Thomas J. H. Chen, D. Comings, B. Meshkin, 2007 .

Theoretical Biology and Medical Modelling Activation Instead of Blocking Mesolimbic Dopaminergic Reward Circuitry Is a Preferred Modality in the Long Term Treatment of Reward Deficiency Syndrome (rds): a Commentary

Edu, Thomas J. H. Chen, D. Comings, 2022 .

Theoretical Biology and Medical Modelling Open Access Neurogenetic Interactions and Aberrant Behavioral Co-morbidity of Attention Deficit Hyperactivity Disorder (adhd): Dispelling Myths

Thomas J. H. Chen, D. Comings, B. Meshkin, 2022 .

LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome

Thomas J. H. Chen, K. Blum, E. Braverman, 2008, Advances in therapy.